Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test - AmpliVue(R) Group B Strep Assay

SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) cleara... Diagnostics, FDAQuidel, AmpliVue, Strep assay, Streptococcus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news